These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 33116518)
1. Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells. Ibrahim WN; Muizzuddin Bin Mohd Rosli L; Doolaanea AA Int J Nanomedicine; 2020; 15():8059-8074. PubMed ID: 33116518 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells. Ahmad R; Kaus NHM; Hamid S Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443 [TBL] [Abstract][Full Text] [Related]
3. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release. Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001 [TBL] [Abstract][Full Text] [Related]
4. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. Bhattacharya S; Ahir M; Patra P; Mukherjee S; Ghosh S; Mazumdar M; Chattopadhyay S; Das T; Chattopadhyay D; Adhikary A Biomaterials; 2015 May; 51():91-107. PubMed ID: 25771001 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377 [TBL] [Abstract][Full Text] [Related]
6. Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles. Noor NS; Kaus NHM; Szewczuk MR; Hamid SBS Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502328 [TBL] [Abstract][Full Text] [Related]
7. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization. Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807 [TBL] [Abstract][Full Text] [Related]
8. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma. Lee SY; Koo JS; Yang M; Cho HJ J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352 [TBL] [Abstract][Full Text] [Related]
9. Development, Optimization, and in vitro Evaluation of Silybin-loaded PLGA Nanoparticles and Decoration with 5TR1 Aptamer for Targeted Delivery to Colorectal Cancer Cells. Rahimnia SM; Saeedi M; Akbari J; Morteza-Semnani K; Hedayatizadeh-Omran A; Yazdian-Robati R AAPS PharmSciTech; 2024 Jun; 25(6):141. PubMed ID: 38898204 [TBL] [Abstract][Full Text] [Related]
10. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody. Eivazi N; Rahmani R; Paknejad M Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796 [TBL] [Abstract][Full Text] [Related]
11. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties, Shaarani S; Hamid SS; Mohd Kaus NH Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648 [TBL] [Abstract][Full Text] [Related]
12. Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability. Guimarães PP; Oliveira SR; de Castro Rodrigues G; Gontijo SM; Lula IS; Cortés ME; Denadai ÂM; Sinisterra RD Molecules; 2015 Jan; 20(1):879-99. PubMed ID: 25580685 [TBL] [Abstract][Full Text] [Related]
13. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and Akhter MH; Kumar S; Nomani S Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984 [No Abstract] [Full Text] [Related]
14. The impact of camptothecin-encapsulated poly(lactic- Bao H; Zhang Q; Yan Z Int J Nanomedicine; 2019; 14():383-391. PubMed ID: 30662262 [TBL] [Abstract][Full Text] [Related]
15. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428 [No Abstract] [Full Text] [Related]
16. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181 [TBL] [Abstract][Full Text] [Related]
17. Preparation and In Vitro/In Vivo Characterization of Polymeric Nanoparticles Containing Methotrexate to Improve Lymphatic Delivery. Jang JH; Jeong SH; Lee YB Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284483 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678 [TBL] [Abstract][Full Text] [Related]
19. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin. Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873 [TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and antiproliferative activity of thymoquinone-beta-cyclodextrin self assembling nanoparticles. Abu-Dahab R; Odeh F; Ismail SI; Azzam H; Al Bawab A Pharmazie; 2013 Dec; 68(12):939-44. PubMed ID: 24400439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]